Condition
FBSS
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed3
Enrolling By Invitation1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07540663Not ApplicableEnrolling By InvitationPrimary
MSCS in BURSTDR Patients
NCT04655833CompletedPrimary
Integrative Korean Medicine Treatment for Inpatients With Failed Back Surgery Syndrome: A Retrospective Study With Survey
NCT03419312Not ApplicableUnknownPrimary
PET Patterns, Biomarkers and Outcome in Burst SCS Treated FBSS Patients
NCT03210766CompletedPrimary
Nabilone and THC/CBD for the Treatment of FBSS Refractory Pain
NCT02787252Not ApplicableCompletedPrimary
Stimwave HF SCS Pilot Study
Showing all 5 trials